Clinical Research Directory

Inclusion Criteria: * Adult women over 18 years of age * Consent to participate in the study * Willingness to undergo examination, treatment and follow-up according to the protocol * DI symptoms characterized by: * Grade III fecal incontinence (patient is unable to consciously hold in wind, loose or hard stools) * At least 2 episodes of fecal incontinence during the week (according to bladder and bowel diary) * At least 1 episode of involuntary urine leakage per day (according to bladder and bowel diary) * Total score of the ICIQ-UI SF questionnaire * DI symptoms for more than 6 months * Failure of previous conservative treatment Exclusion Criteria: * Rapidly progressing neurological diseases * Known severe congenital malformations of the anorectum and/or lower urinary tract * Presence of a foreign body in the urinary tract - urolithiasis, urinary catheter, ureteral stent * Pregnancy, lactation * Active urinary tract infection * Active malignant disease * Clinically significant pelvic organ prolapse * Active inflammatory bowel disease (Crohn's disease, ulcerative colitis) * In the case of an associated lesion of the external anal sphincter, a defect greater than 90 degrees * Previous pelvic radiotherapy less than 12 months prior to study enrolment * Previous pelvic organ descent surgery less than 12 months prior to study enrolment * Previous stress urinary incontinence surgery less than 12 months prior to study enrolment * Previous childbirth less than 12 months prior to study enrollment * Anatomical malformations of the sacrum that preclude implantation of the SNM electrode * Low patient compliance * Inability to control the neurostimulator